Hannah Valantine's Net Worth

$1.4 Million

Estimate Recalculated Jun 30, 2025 09:50PM EST

Who is Hannah Valantine

Hannah Valantine has an estimated net worth of $1.4 Million. This is based on reported shares across multiple companies, which include CareDx, Inc., PACIFIC BIOSCIENCES OF CALIFORNIA, INC., and BridgeBio Pharma, Inc..

SEC CIK

Hannah Valantine's CIK is 0001855608

Past Insider Trading and Trends

2024 was Hannah Valantine's most active year for acquiring shares with 8 total transactions. Hannah Valantine's most active month to acquire stocks was the month of May. 2023 was Hannah Valantine's most active year for disposing of shares, totalling 4 transactions. Hannah Valantine's most active month to dispose stocks was the month of December. 2021 saw Hannah Valantine paying a total of $25,101.72 for 56,123 shares, this is the most they've acquired in one year. In 2024 Hannah Valantine cashed out on 11,660 shares for a total of $220,723.80, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

CareDx, Inc.

Investor
Updated Jun 20, 2024
Form 4/A
16.05K
Jun 20, 2024
16.05K
Grant
Jun 14
Form 4
98.98%
26.62K
Jun 18, 2024
53.51K
Grant
Jun 14
Form 4
596.25%
47.98K
Jun 21, 2023
56.03K
Grant
Jun 16
Form 4
9.17%
676.00
Jan 09, 2023
8.05K
Grant
Jan 06
Form 4
6.07%
422.00
Oct 04, 2022
7.37K
Grant
Oct 04
Form 4
4.91%
325.00
Jul 06, 2022
6.95K
Grant
Jul 01
Form 4
708.06%
12.47K
Jun 21, 2022
14.23K
Grant
Jun 16
Form 4
8.04%
131.00
Oct 04, 2021
1.76K
Grant
Oct 01
Form 4
3.26K
Jul 02, 2021
3.26K
Grant
Jul 01
Form 3
Jul 02, 2021
Showing 10 results

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Investor
Updated Jun 20, 2024
Form 4
55.00K
Jun 20, 2024
55.00K
Grant
Jun 18
Form 4
25.77K
May 26, 2023
25.78K
Grant
May 24
Form 4
63.02K
May 27, 2022
63.02K
Grant
May 25
Form 3
Jun 21, 2021
Showing 4 results

BridgeBio Pharma, Inc.

Investor
Updated Jun 30, 2025
Form 4/A
113.62%
1.75K
$14.24
$24.95K
Jun 30, 2025
5.98K
Purchase
Dec 29
Form 4/A
123.64%
2.34K
$12.92
$30.03K
Jun 30, 2025
4.23K
Purchase
Dec 28
Form 4
26.01K
Jun 25, 2024
26.01K
Grant
Jun 21
Form 4
-2.98%
-2.92K
$23.10
-$85.41K
Feb 20, 2024
98.46K
Sale
Feb 15
Form 5
3.43K
$12.96
$44.48K
Feb 13, 2024
5.20K
Purchase
Dec 28
Form 4
3.43K
$12.96
$44.48K
Feb 13, 2024
3.43K
Purchase
Dec 28
Form 4
-2.89%
-2.92K
$23.21
-$86.05K
Jan 18, 2024
97.94K
Sale
Jan 16
Form 4
-2.81%
-2.92K
$22.28
-$80.66K
Dec 19, 2023
100.86K
Sale
ScheduledDec 15
Form 4
-2.73%
-2.92K
$19.23
-$62.82K
Nov 17, 2023
103.77K
Sale
ScheduledNov 15
Form 4
51.50K
Jun 23, 2023
51.50K
Grant
Jun 21
Form 4
104.92K
Jun 24, 2022
104.92K
Grant
Jun 22
Form 4
1.76K
$14.23
$25.10K
Jan 03, 2022
1.76K
Purchase
Dec 29
Form 4
50.97K
Oct 26, 2021
50.97K
Grant
Oct 25
Form 3
Oct 26, 2021
Showing 14 results